Chronic graft versus host disease is associated with an immune response to autologous human leukocyte antigen-derived peptides

Transplantation

Volumn 90, Issue 5, 2010, Pages 555-563

  Smith, Helen J ^a   Hanvesakul, Rajesh ^a   Morgan, Matthew D ^a   Bentall, Andrew ^a   Briggs, David ^b   Clark, Fiona ^c   Pratt, Guy ^a   Moss, Paul ^a   Larché, Mark ^d   Ball, Simon ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

cGVHD; HLA; Peptide

Indexed keywords

AUTOANTIGEN; CORTICOSTEROID; CYCLOSPORIN A; GAMMA INTERFERON; LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; HLA ANTIGEN; HLA ANTIGEN CLASS 1;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PHOTOTHERAPY; PRIORITY JOURNAL; ALLOTRANSPLANTATION; BIOSYNTHESIS; BLOOD; GRAFT VS HOST DISEASE; HUMORAL IMMUNITY; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOCYTE; PROCEDURES;

BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOPHENOTYPING; INTERFERON-GAMMA; LEUKEMIA; LYMPHOCYTES; MALE; TRANSPLANTATION, HOMOLOGOUS;

EID: 77957261531     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181e86b58     Document Type: Article

References (32)

1. Schultz KR, Miklos DB, Fowler D, et al. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. Biol Blood Marrow Transplant 2006; 12: 126.
2. Gallardo D, Arostegui JI, Balas A, et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol 2001; 114:931.
3. Akatsuka Y, Warren EH, Gooley TA, et al. Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling.Br J Haematol 2003; 123: 671. www.lumc.nl/rep/cod/redirect/5033/dbminor. in. Accessed June 2010.
4. Giorgini A, Noble A. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in non-lymphopenic hosts. JLeukocBiol 2007; 82: 1053.
5. Chen X, Vodanovic-Jankovic S, Johnson B, et al. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 2007; 110: 3804.
6. Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: The effect of donor age. Blood 2001; 98: 2043.
7. Hanvesakul R, Maillere B, Briggs D, et al. Indirect recognition of T-cell epitopes derived from the alpha 3 and transmembrane domain of HLA-A2. Am J Transplant 2007; 7: 1148.
8. Boisgerault F, Anosova NG, Tam RC, et al. Induction of T-cell response to cryptic MHC determinants during allograft rejection. Hum Immu-nol2000; 61: 1352.
9. Lovegrove E, Pettigrew GJ, Bolton EM, et al. Epitope mapping of the indirect T cell response to allogeneic class I MHC: Sequences shared by donor and recipient MHC may prime T cells that provide help for alloantibody production. J Immunol 2001; 167: 4338.
10. Sercarz EE, Lehmann PV, Ametani A, et al. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993; 11: 729.
11. Hanvesakul R, Smith H, Bentall A, et al. Indirect allorecognition of HLA 'public' T cell epitopes is associated with chronic allograft dysfunction. TransplInt2009; 22(s2): 51.
12. Benichou G, MalloyKM, TamRC, et al. The presentation of self and allogeneic MHC peptides to T lymphocytes. Hum Immunol 1998; 59: 540.
13. Frasca L, Amendola A, Hornick P, et al. Role of donor and recipient antigen-presenting cells in priming and maintaining T cells with indirect allospecificity. Transplantation 1998; 66: 1238.
14. Waanders MM, Heidt S, Koekkoek KM, et al. Monitoring of indirect allorecognition: Wishful thinking or solid data? Tissue Antigens 2008; 71: 1.
15. Jiang X, Moudgil KD. The unveiling of hidden T-cell determinants of a native antigen by defined mediators of inflammation: Implications for the pathogenesis of autoimmunity. Scand J Immunol 2006; 63: 338.
16. Patriarca F, Skert C, Sperotto A, et al. The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery. Exp Hematol 2006; 34:389.
17. Imanguli MM, Swaim WD, League SC, et al. Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa. Blood 2009; 113: 3620.
18. De Wit D, Van Mechelen M, Zanin C, et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol 1993; 150: 361.
19. Zorn E, Miklos DB, Floyd BH, et al. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. JExp Med 2004; 199: 1133.
20. Chicz RM, Urban RG, Lane WS, et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992; 358: 764.
21. Hess AD, Thoburn CJ. Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: Role of regulatory T cells. Biol Blood Marrow Transplant 2006; 12: 518.
22. Adams KM, Holmberg LA, Leisenring W, et al. Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation. Blood 2004; 104: 1894.
23. Van Rood JJ. HLA and I. Annu Rev Immunol 1993; 11: 1.
24. Verdijk RM, Kloosterman A, Pool J, et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: Implications for stem cell transplantation and immunotherapy. Blood 2004; 103: 1961.
25. Suh CH, Freed JH, Cohen PL. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice. J Immunol 2003; 170:2229.
26. Fedoseyeva EV, Tam RC, Popov IA, et al. Induction of T cell responses to a self-antigen following allotransplantation. Transplantation 1996; 61: 679.
27. Valujskikh A, Fedoseyeva E, Benichou G, et al. Development of autoimmunity after skin graft rejection via an indirect alloresponse. Transplantation 2002; 73: 1130.
28. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945.
29. Arif S, Tree TI, Astill TP, et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 2004; 113: 451.
30. Goon PK, Hanon E, Igakura T, et al. High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood 2002; 99: 3335.
31. Kudela P, Janjic B, Fourcade J, et al. Cross-reactive CD4+ T cells against one immunodominant tumor-derived epitope in melanoma patients. J Immunol 2007; 179: 7932.
32. Litjens NH, Huisman M, Baan CC, et al. Hepatitis B vaccine-specific CD4(+) T cells can be detected and characterised at the single cell level: Limited usefulness of dendritic cells as signal enhancers. J Immunol Methods 2008; 330: 1.